When analyzing the TCGA-SKCM dataset, we used the tumor immune dysfunction and exclusion (TIDE) method to assess the potential clinical efficacy and response to immunotherapy in different YTHDF1 subgroups26. The gene discussed is YTHDF1; the disease is neoplasm.